Dexcom CEO Hints at a Diabetes Collaboration with Apple Watch

Apple is consistently adding health-related features to the Apple Watch. Dexcom is a company that offers FDA-approved blood glucose monitoring kit. In the past Dexcom has partnered with Fitbit to display glucose monitoring data on the Ionic smartwatch. Recently, the CEO of Dexcom has teased a collaboration with Apple.

Kevin Sayer, CEO of Dexcom told CNBC that the partnership will allow users to track glucose on their Apple Watch. He further added that “It’s coming,” “And this tool is great for people with diabetes.”

Dexcom had already partnered with Apple Watch and this allowed users to check information from the Dexcom G6 Transmitter on the Apple Watch. The company is believed to be launching a slew of upgrades to its G6 diabetes system and this will also include direct support for Apple Watch. It is worth noting that Dexcom’s monitoring devices already allow glucose data to be transmitted to Apple Watch with the help of an app. In all likelihood, the new native solution will offer more advanced features.

Our Take

As mentioned earlier, Apple is bullish about shaping up their Watch as a health monitoring device. The latest iteration of Apple Watch arrived with features like ECG and a sensor that would alert if the user falls. Tim Cook has been vocal about how health-related features will help Apple Watch stand out of the crowd.

Dexcom G6 is a Continuous Glucose Monitoring System. This means no pricking your fingers every-time you want to measure the glucose level in your blood. According to WHO, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Furthermore, Diabetes is also found to be the major cause of blindness, kidney failure, heart attacks, strokes, and other diseases.

Glucose Monitoring is a crucial aspect of living life with diabetes. Health monitoring system like the G6 coupled with Apple Watch will offer a quick and easy way to keep a tab on your glucose level, without having to go to the clinic.

[via CNBC]